Navigation Links
Mayo Clinic chest surgeons propose measures for indicating quality of lung surgery
Date:9/9/2008

ROCHESTER, Minn. - Even though 30,000 patients in the United States undergo lung surgery each year, no standard criteria exist to measure the quality of their care. In the current issue of The Annals of Thoracic Surgery, Mayo Clinic surgeons have proposed a system of lung surgery quality indicators for surgeons and the public as a method to demonstrate best practices for obtaining positive patient outcomes.

Death rates following surgery are frequently reported. However, because they aren't adjusted for factors such as patient age and disease severity, they don't tell the whole story. To overcome this lack of risk adjustment in death rate data, the Mayo Clinic team proposed patient-centered processes that should occur prior to, during and after surgery to assure the likelihood of best surgical outcomes.

"There are certain processes that we can measure and report that clearly indicate whether patients have received high-quality care around the time of their lung operation," explains Stephen Cassivi, M.D., Mayo Clinic thoracic surgeon and lead study author.

"Knowing this data can help patients decide about the care they are about to receive and where to go to receive that care - and equally important, this knowledge can help chest surgery programs improve their quality of care by concentrating on identified weaknesses," Dr. Cassivi says. "Creating standards through measures of process will allow for directed quality improvement initiatives across all surgical centers."

The criteria were first presented at the 2007 Annual Meeting of the Society of Thoracic Surgeons.

In an accompanying editorial in the same issue of The Annals of Thoracic Surgery, Alex Little, M.D., chair of the department of surgery at Wright State Boonshoft School of Medicine, Dayton, Ohio, asserts that developing these process measures of quality to improve patient outcomes has a "certain moral imperative." The editorial goes on to state: "We
'/>"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development
2. September 2008 Mayo Clinic Womens HealthSource Highlights Normal Weight Obesity, Regular Exercise and Cholesterol
3. VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients
4. Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania
5. Shaping Best Practices For Standardized Medical Imaging In Clinical Trials
6. Cleveland Clinic Launches Fully Dedicated International Comprehensive Critical Care Program
7. Fairview and Blue Cross and Blue Shield of Minnesota Reach Contract Agreement for Clinics and Hospitals
8. New probe to detect skin cancer receives more funding for clinical trials
9. Prototype test for predicting clinical outcome for melanoma patients
10. Study finds a wide variety of errors in testing process at family medicine clinics
11. Roskamp Institutes Associate Clinic Director Named Chairperson of the Alzheimers Disease Initiative Advisory Committee

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...C, Nov. 27 /PRNewswire/ - Uploadable USB pedometer...e in wellness. A combination of advanced accelerom...olving a long term concern over the accuracy of se...gauge and reward improved participation in a fitne...f the first wellness suppliers to integrate this t...
(Date:11/27/2009)...SCO, Nov. 27 The Gymbore...r Lambert, CFO/COO, will present at the NASDAQ OMX...May Fair Hotel in London, England, on Wednesday, D...n to a live broadcast of The Gymboree Corporation,... www.gymboree.com, click on "Our Company" at the b...
(Date:11/27/2009)...AMIR, Israel, Nov. 27 Sh...mir" ), a leading provider of innovative products ...unced today that its board of directors had declar...of US$ 10 million (approximately NIS 37.62 million...e of exchange), or approximately US$ 0.609 (approx...
(Date:11/27/2009)...g unprecedented medical, economic burdens, study p...ews) -- The number of people with diabetes in the ...25 years, a new study predicts. , That would br... with the disease, up from 23.7 million today. , ...ith diabetes will triple, the study also warns, ri...
(Date:11/27/2009)... Multi-purpose bilingual coloring books design...the business community to educate - inform parents...Safety issues to Dinosuars to ABC,S and a host of ...is, MO (PRWEB) November 27, 2009 -- Today’s ...to keep them busy any hour of the day, but one of ...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...oea Association (BSSAA) reveals that snoring affec...a detrimental effect on health and ruins sex lives... has brought out an anti snore bedroom which has s...dy conducted by the BSSAA, 15 million people in th...
...kins today unanimously voted to support behind Mar... indoor public spaces in the state. A resol...kins Medicine Board of Trustees stated that the Bo...legislation banning smoking in all indoor public s...
...ed fish are enormous and especially children and w...how much// and which fish they eat says-"The Madis...ay in a special issue of the international science...is a synopsis of the latest scientific knowledge a...
...are among a variety of autoimmune diseases that ar...lled the immune regulatory// cell, malfunctions. I...mutation in the FOXP3 gene disables the immune cel...ty of Pennsylvania School of Medicine have discove...
...n lead to inappropriate treatment for their childr...ns Hopkins// University undergraduate in Africa co... – interviews, stool samples and medical records –...ent diarrheal disease or manage it. Diarrhe...
...onic stem cells to send cannibalistic signals to h...he way for normal mammalian// development. A...d or damaged parts. It was known to be active in c...ctually help keep cells alive. The novel rol...
Other Medicine News:Health News:Johns Hopkins Medicine Trustees Support Smoking Ban In Public Spaces 2Health News:Methylmercury in Marine Fish Pose Health Risks to Pregnant Women and Elderly Men 2Health News:Methylmercury in Marine Fish Pose Health Risks to Pregnant Women and Elderly Men 3Health News:Researchers Discover New Molecular Path to Fight Autoimmune Diseases 2Health News:Mothers in African Study Undereducated on Diarrhea 2Health News:Mothers in African Study Undereducated on Diarrhea 3Health News:Cannibalistic Signals Help Mammalian Embryos Develop Normally 2Health News:Cannibalistic Signals Help Mammalian Embryos Develop Normally 3
(Date:11/25/2009)...The Netherlands and JOHANNESBURG, November 25 /PRN...ion and Pyxis Discovery announced today,that they ...arket both,companies, services. , Pyxis,s...overy expertise,will be coupled with iThemba,s ser...hemistry support to projects identified through Py...
(Date:11/25/2009)...Calif., Nov. 25 ChemoCentryx, In...a from the Company,s PROTECT-1 (the Prospective Ra...e Trial) of Traficet-EN(TM) (CCX282-B) in patients...ted clinical efficacy with a favorable safety and ...ence of clinical efficacy in the reduction of dise...
(Date:11/24/2009)...ov. 24 ,, WHAT: Rom Houbens, ...years following an auto accident, was actually ful...e subject of a Good Morning America segment. The ...strate how people with Locked-in Syndrome and othe... Good Morning America -- Tuesday, November 24 a...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Arizona Heart Institute Enrolls First Patient in Anaconda 28TM 29 Investigational Study for the Treatment of Abdominal Aortic Aneurysm 49462 1Arizona Heart Institute Enrolls First Patient in Anaconda 28TM 29 Investigational Study for the Treatment of Abdominal Aortic Aneurysm 49462 2Arizona Heart Institute Enrolls First Patient in Anaconda 28TM 29 Investigational Study for the Treatment of Abdominal Aortic Aneurysm 49462 3Lytix Biopharma and KAEL GemVax Announce Joint Clinical Trial to Combine LTX 315 and GV1001 Cancer Immunotherapy 12707 1Lytix Biopharma and KAEL GemVax Announce Joint Clinical Trial to Combine LTX 315 and GV1001 Cancer Immunotherapy 12707 2NeuroTherm Completes Acquisition of the Micron Epidural Catheter 49458 1NeuroTherm Completes Acquisition of the Micron Epidural Catheter 49458 2
...tigator Meeting for European Participants in Phase...d Population, BERKELEY HEIGHTS, N.J., Sept. 5 /PR... GNTA ) announced that data from the Company,s Pha...s chemotherapy would be,presented at the opening s...ing organized by the European Association of Derma...
... Data Scheduled for Presentation at 47th ICAAC on ...ARLSBAD, Calif., Sept. 4 Ardea Biosciences,Inc. (...cessfully completed,Phase 1 single-ascending-dose,...teraction studies of RDEA806, a novel HIV non-nucl... healthy volunteers. The data from these Phase 1 ...
Other Medicine Technology:Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 2Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 3Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 4Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology 5Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: